Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection

Stefan Zeuzem,Reem Ghalib,K. Rajender Reddy,Paul J. Pockros,Ziv Ben-Ari,Yue Zhao,Deborah D. Brown,Shuyan Wan,Mark J. DiNubile,Bach-Yen Nguyen,Michael N. Robertson,Janice Wahl,Eliav Barr,Joan R. Butterton

Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection

2020

Stefan Zeuzem
Reem Ghalib
K. Rajender Reddy
Paul J. Pockros
Ziv Ben-Ari
Yue Zhao
Deborah D. Brown
Shuyan Wan
Mark J. DiNubile
Bach-Yen Nguyen
Michael N. Robertson
Janice Wahl
Eliav Barr
Joan R. Butterton

Various oral interferon- and ribavirin-free regimens are becoming available to treat chronic hepatitis C virus (HCV) infection. This phase 3 trial evaluates the effectiveness and tolerability of a ...

Keywords:

Viral load
Grazoprevir
Hepatocellular carcinoma
Elbasvir
Combination therapy
Interferon
Internal medicine
Gastroenterology
Tolerability
Virus
Medicine
Cardiology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations